Grace Therapeutics (GRCE) Other Non-Current Assets (2018 - 2022)

Grace Therapeutics has disclosed Other Non-Current Assets across 5 years of filings, most recently posting $352000.0 for Q4 2022.

• In Q4 2022, Other Non-Current Assets fell 40.03% year-over-year to $352000.0; the TTM figure through Dec 2022 stood at $352000.0 (down 40.03% YoY), while the FY2022 annual figure was $352000.0, down 54.17% from the prior year.
• Other Non-Current Assets came in at $352000.0 for Q4 2022 at Grace Therapeutics, roughly flat from $352000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.6 million in Q1 2020 to a low of $352000.0 in Q1 2022.
• Average Other Non-Current Assets over 5 years is $764150.7, with a median of $639000.0 recorded in 2020.
• Year-over-year, Other Non-Current Assets soared 451.2% in 2020 and tumbled 70.21% in 2021.
• Over 5 years, Other Non-Current Assets stood at $521403.5 in 2018, then fell by 10.3% to $467706.3 in 2019, then surged by 132.62% to $1.1 million in 2020, then sank by 46.05% to $587000.0 in 2021, then slumped by 40.03% to $352000.0 in 2022.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $352000.0 in Q4 2022, $352000.0 in Q3 2022, and $352000.0 in Q2 2022.